In fiscal year 2025, Finemedix (387570) reported revenue of 9.5 billion KRW.
Income Statement
| Year | Revenue | Op Profit | Net Income | Source |
|---|---|---|---|---|
| 2025 | 9.5 billion KRW | -2.6 billion KRW | -1.9 billion KRW | [source] |
| 2024 | 10.0 billion KRW | -29 million KRW | -24 million KRW | [source] |
| 2023 | 10.2 billion KRW | 874 million KRW | 1.2 billion KRW | — |
| 2022 | 8.1 billion KRW | -661 million KRW | 240 million KRW | — |
Balance Sheet
| Year | Total Assets | Total Liabilities | Total Equity | Source |
|---|---|---|---|---|
| 2025 | 27.1 billion KRW | 6.3 billion KRW | 20.7 billion KRW | [source] |
| 2024 | 28.0 billion KRW | 5.9 billion KRW | 22.1 billion KRW | [source] |
| 2023 | — | — | — | — |
| 2022 | — | — | — | — |
Years without a source link are outside the DART financial API collection period.
Balance sheet figures for the relevant year were not collected.